免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

PixoTest 血糖监测系统

K号: K163087 · 2017-11-02

决定日期2017-11-02
产品代码NBW
咨询委员会CH 请注意,您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

PixoTest Blood Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Ixensor Company , Ltd.. It received FDA 510(k) clearance on 2017-11-02 under 510(k) number K163087. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

常见问题

What is the PixoTest Blood Glucose Monitoring System?

PixoTest Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2017-11-02. The listed applicant is Ixensor Company , Ltd.. The 510(k) number is K163087.

When did PixoTest Blood Glucose Monitoring System receive FDA 510(k) clearance?

PixoTest Blood Glucose Monitoring System received FDA 510(k) clearance on 2017-11-02, under 510(k) number K163087.

Who is the listed applicant for PixoTest Blood Glucose Monitoring System?

The FDA 510(k) record lists Ixensor Company , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PixoTest Blood Glucose Monitoring System?

The FDA product code for PixoTest Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NBW)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑